GEHC
NASDAQ · Health Care
Ge Healthcare Technology
$72.20
+1.24 (+1.75%)
Financial Highlights (FY 2026)
Revenue
20.74B
Net Income
2.10B
Gross Margin
40.0%
Profit Margin
10.1%
Rev Growth
+4.0%
D/E Ratio
0.97
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 40.0% | 40.0% | 42.3% | 42.3% |
| Operating Margin | 13.4% | 12.1% | 13.2% | 14.7% |
| Profit Margin | 10.1% | 9.6% | 10.0% | 10.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 20.74B | 19.94B | 15.42B | 13.77B |
| Gross Profit | 8.29B | 7.98B | 6.51B | 5.82B |
| Operating Income | 2.78B | 2.41B | 2.03B | 2.03B |
| Net Income | 2.10B | 1.81B | 1.54B | 1.48B |
| Gross Margin | 40.0% | 40.0% | 42.3% | 42.3% |
| Operating Margin | 13.4% | 12.1% | 13.2% | 14.7% |
| Profit Margin | 10.1% | 9.6% | 10.0% | 10.8% |
| Rev Growth | +4.0% | +4.0% | -4.4% | +20.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 7.89B | 7.89B | 3.20B | 2.89B |
| Total Equity | 8.15B | 8.15B | 21.16B | 22.20B |
| D/E Ratio | 0.97 | 0.97 | 0.15 | 0.13 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 3.37B | 3.08B | 2.74B | 2.82B |
| Free Cash Flow | — | — | 1.88B | 1.51B |